Institute of Oncology NN Petrov

Recent papers from Institute of Oncology NN Petrov

1. Russian consensus on unresolved issues in the diagnosis and treatment of patients with adenomas of the major duodenal papillaКлиническая эндоскопия. · 2026
2. KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non–Small Cell Lung CancerJournal of Clinical Oncology · 2026
3. Emotional State in Patients with Cancer: Subjective Asessment by Accompanying RelativesBulletin of psychotherapy · 2026
4. mPEG-b-PCL-Based Nanoformulations of Aziridine-Functionalized 1,3,5-Triazine Derivative for Cancer TreatmentPolymers · 2026
5. The Dual Role of Cell Death in Cancer Pathogenesis and Antitumor Therapy: From Linear Models to Integrative RepresentationsBiochemistry (Moscow) · 2026
6. The challenge of evaluating the efficacy of neoadjuvant endocrine therapy in breast cancer and potential solutions: a literature reviewMedical alphabet · 2026
7. Efficacy and Safety of EG12014 (Biosimilar Trastuzumab) Compared to Reference Trastuzumab in HER2-Positive Early Breast Cancer: A Phase III Randomized StudyAdvances in Therapy · 2026
8. Randomized Prospective Comparison Between Neoadjuvant Mitomycin C Plus Cisplatin and Paclitaxel Plus Carboplatin in Patients With BRCA1 ‐Associated Ovarian CancerInternational Journal of Cancer · 2026
9. Breast–Ovarian Hereditary Cancer Syndrome: Beyond BRCA1 and BRCA2Current Oncology · 2026
10. Safety and Performance of the Colovac Anastomosis Protection Device. A Pooled Analysis of Prospective Studies Compared With Diverting Loop Ileostomy (SAFE-2025)Annals of Surgery · 2026
11. 5′ Rapid Amplification of cDNA Ends (5′ RACE)-Based Targeted RNA Sequencing Assay for the Analysis of Clinically Relevant Alterations in Lung Cancer PatientsInternational Journal of Molecular Sciences · 2026
12. Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer SocietyExploration of Targeted Anti-tumor Therapy · 2026
13. A Binary DNAzyme Machine (BDM) for Selective Amplification-Free Detection of microRNARussian Journal of Bioorganic Chemistry · 2026
14. An Endemic Region of Thiamine-Responsive Megaloblastic Anemia Caused by an SLC19A2 c.1223+1G>A Founder MutationInternational Journal of Molecular Sciences · 2026
15. Identification of Proteomic Markers for Monitoring Direct Toxic Liver Injury (DTLI): Profiling Hepatoprotective Effects of Plant PolyphenolsInternational Journal of Molecular Sciences · 2026
16. Myxoid Variant of Primary Cutaneous Anaplastic Large Cell Lymphoma Mimicking Soft Tissue Sarcoma: Diagnostic Pitfalls and Literature ReviewAmerican Journal of Dermatopathology · 2026
17. Real-world outcomes of glofitamab therapy in CAR-T–naïve patients with relapsed/refractory large B-cell lymphomaBlood Immunology & Cellular Therapy · 2026
18. Efficacy and Safety of Various Treatment Regimens for Primary CNS Lymphoma: Results of a Retrospective Study Based on the Data from Nine Saint Petersburg Medical InstitutionsClinical oncohematology · 2026
19. Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR ‐Mutated Locally Advanced or Metastatic Lung CancerInternational Journal of Cancer · 2026
20. ChatGPT-based conversational AI tool for training oncologists in patient communication: A real-world implementation study.Journal of Clinical Oncology · 2026